FDA Drugs recall ·

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial… recall

This is an FDA Class I recall — the most serious type.

Recall number
D-0005-2025
Date
(initiated September 19, 2024)
Company / brand
Gilead Sciences, Inc.
333 Lakeside Dr, Foster City, CA, United States
Category
Drugs › Class I
Classification
Class I
Status
Terminated
Units affected
105,000 vials
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Why was it recalled?

Presence of Particulate Matter: Presence of glass particle.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot: 47035CFA, Exp. 11/2025

Distribution

Nationwide in the U.S.A.

What does Class I mean?

Class I is the most serious FDA recall class: there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.

Source: FDA (drugs), recall D-0005-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.